Lertus - Lertus is an antifungal drug from the group of triazole derivatives. Inhibits the synthesis of ergosterol disrupting the permeability of the cell wall. This medication is active against Candida, Microsporum, Cryptococcus neoformans, Trichophyton.
NSAIDs, a derivative of phenylacetic acid, Lertus has a pronounced anti-inflammatory, analgesic and mild antipyretic effect. The mechanism of action is associated with inhibition of COX activity - the main enzyme metabolism of arachidonic acid, which is a precursor of prostaglandins, which play a major role in the pathogenesis of inflammation, pain and fever. Analgesic effect is due to two mechanisms: peripheral (indirectly, through suppression of prostaglandin synthesis) and central (due to inhibition of prostaglandin synthesis in the central and peripheral nervous system).
Inhibits synthesis of proteoglycan in cartilage.
In rheumatic diseases, Lertus reduces joint pain at rest and in motion, as well as morning stiffness and swelling of the joints, helps to increase range of motion; reduces post-traumatic and postoperative pain, and inflammatory edema.
Inhibits platelet aggregation. With prolonged use has a desensitizing effect.
When used topically in ophthalmology reduces swelling and pain in inflammatory processes non-infectious etiology.
Lertus is a nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties. Lertus has pharmacologic actions similar to those of other prototypical NSAIDs, that is thought to be associated with the inhibition of prostaglandin synthesis. Lertus is used to treat rheumatoid arthritis, osteoarthritis, dysmenorrhea, and to alleviate moderate pain.
Indication: For the treatment of pain (muscular and rheumatic), sprains, strains, backache and neuralgia and for the management of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
Indications: pain, musculoskeletal, joint, and peri-articular disorders, inflammation
Indications: fungal infections
Indications: fever, gout, inflammation, musculoskeletal, joint, peri-articular, and soft-tissue disorders, pain
Inflammatory joint diseases (including acute attacks of gout).Chronic inflammatory joint diseases, particularly rheumatoid arthritis (chronic polyarthritis).Osteoarthritis. Ankylosing spondylitis and other rheumatic inflammation of the spine. Irritation resulting from degenerative joint disease and pain syndromes of the spine (osteoarthritis activated and espondilartrosis, cervical syndrome, lumbago, sciatica).Non-articular rheumatism. Painful post-traumatic and postoperative swellings and bruises and swelling after surgery. Primary dysmenorrhea. Adnexitis acute or subacute. Pain due to cancer, particularly osteo-skeletal origin of peritumoral edema or inflammation. As an adjunct in the treatment of serious infectious processes, accompanied by pain. Inflammation of the ear, nose or throat, for example, in pharyngitis and otitis, respecting the general treatment principles where the basic disease should be treated properly. There is an indication of only fever.
Lertus Gunther do Brasil Produtos Farmaceuticos is an antifungal drug from the group of triazole derivatives. Inhibits the synthesis of ergosterol disrupting the permeability of the cell wall. This medication is active against Candida, Microsporum, Cryptococcus neoformans, Trichophyton.
Bursitis,Tendinitis,Pain and inflammation associated with musculoskeletal and joint disorders,Acute gout,Dysmenorrhoea,Migraine,Postoperative pain,Prophylaxis of postoperative pain,Strains,Tendinitis,Renal colic,Prophylaxis of intra-operative miosis,Post-photorefractive keratectomy pain,Seasonal allergic conjunctivitis,Control of inflammation after argon laser trabeculoplasty,Inflammation and discomfort after strabismus surgery,Pain after accidental trauma,Local symptomatic relief of pain and inflammation,Osteoarthritis.